Top Markets
Coin of the day
Roquefort Therapeutics plc Roquefort Therapeutics plc

Roquefort Therapeutics plc

ROQ
Rang in aandelen #37956
Roquefort Therapeutics plc functions as a biotechnology firm, focusing its... Roquefort Therapeutics plc functions as a biotechnology firm, focusing its efforts on the discovery and development of innovative pharmaceutical treatments. The company's primary research objective is to develop therapies that target Midkine, a circulating growth factor protein and pro-inflammatory mediator, for applications in cancer treatment. Established in 2020, Roquefort Therapeutics plc has its main operations based in London, United Kingdom.
Aandeelprijs
$0.10205262
Laatst gesynchroniseerd: 2026-04-23
Marktkapitalisatie
$1.32M
Verandering (1 dag)
5.19%
Verandering (1 jaar)
-54.38%
Land
GB
Handel Roquefort Therapeutics plc (ROQ)

Categorie

Koersgeschiedenis voor Roquefort Therapeutics plc (ROQ)
Hoogste slotkoers: $0.11 op 2026-04-01

Laagste slotkoers: $1.11 op 2021-03-01
Koersgeschiedenis van Roquefort Therapeutics plc van 2021 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 5.75%
2025 -65.57%
2024 -41.05%
2023 6.79%
2022 -46.27%
2021 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE